PTC Therapeutics' Translarna loses EU conditional approval, but countries may allow continued use. PTC submitted four FDA ...

Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically ...

Shanghai Henlius Biotech, Inc. (2696) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has valida ...

Opinion: Kirkland & Ellis attorneys Karthik Ravishankar, Kristina Cary, and Jenny Quang write that two recent decisions ...

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for ...

TOMI™ Environmental Solutions, Inc.: Innovating for a safer world® ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, ...

This is the third of a five-part series. Part one is here, part two is here and part three is here, and part four is here. Diana Nachtigal Diana Nachtigal is Captain of Community Engagement for the ...

Every so often, Wall Street sends a not-so-subtle reminder to investors that stocks can move in both directions. Between the ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Akre Capital Management follows a disciplined investment philosophy centered around identifying exceptional businesses ...

We recently published a list of 15 Best Defensive Stocks Amid Market Volatility In this article, we are going to take a look ...